MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
Miltenyi Biomedicine GmbH
Miltenyi Biomedicine GmbH
Merck Sharp & Dohme LLC
Gilead Sciences
BeOne Medicines
C Ray Therapeutics
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Aragon Pharmaceuticals, Inc.
Novartis
Aragon Pharmaceuticals, Inc.
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Eli Lilly and Company
Janssen Pharmaceutical K.K.
RayzeBio, Inc.
Pfizer
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Eli Lilly and Company
TOLREMO therapeutics AG
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
IDEAYA Biosciences
OncoC4, Inc.
Revolution Medicines, Inc.
Genmab
USWM, LLC (dba US WorldMeds)
Hangzhou Sumgen Biotech Co., Ltd.
Seagen Inc.
Seagen Inc.
Seagen Inc.
Pfizer
ARTBIO Inc.
AstraZeneca
BeOne Medicines
Iovance Biotherapeutics, Inc.